100% agree. All that mattered from this trial was are the results good enough to go to the next stage. This Phase 2 trial was a proof of concept trial, not a preventative or therapeutic trial. The results from both the 2a and 2b enable ILA to now run real pivotal field trials that will prove (or disprove) if ISLA-101 has utility in Dengue.
ILA Price at posting:
18.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)